DNA methylation and histone modifications in breast cancer

Methods in Molecular Biology

Volumn 863, Issue , 2012, Pages 35-45

  Dumitrescu, Ramona G ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; DNA promoter hypermethylation; Global hypomethylation; Histones acetylation; Histones deacetylases; Histones methylation

Indexed keywords

HISTONE;

ARTICLE; BREAST TUMOR; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NUCLEOSOME; PHYSIOLOGY;

BREAST NEOPLASMS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; NUCLEOSOMES;

EID: 84859971532     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-612-8_3     Document Type: Article

References (70)

1. American Cancer Society. Cancer Facts and Figures 2010. (2010). Atlanta, Georgia, American Cancer Society.
2. Hanahan, D. and Weinberg, R. A. (2000) The hallmarks of cancer. Cell 100, 57-70. (Pubitemid 30046295)
3. Polyak, K. (2007) Breast cancer: Origins and evolution. J. Clin. Invest 117, 3155-3163. (Pubitemid 350096968)
4. Vogelstein, B. and Kinzler, K. W. (2004) Cancer genes and the pathways they control. Nat Med 10, 789-799. (Pubitemid 39070849)
5. Widschwendter, M. and Jones, P. A. (2002) DNA methylation and breast carcinogenesis. Oncogene 21, 5462-5482. (Pubitemid 34983482)
6. Baylin, S. B. and Ohm, J. E. (2006) Epigenetic gene silencing in cancer-A mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6, 107-116. (Pubitemid 43361543)
7. Eden, A., Gaudet, F., Waghmare, A., and Jaenisch, R. (2003) Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300, 455. (Pubitemid 36444319)
8. Feinberg, A. P. and Tycko, B. (2004) The history of cancer epigenetics. Nat Rev Cancer 4, 143-153. (Pubitemid 38198742)
9. Lo, P. K. and Sukumar, S. (2008) Epigenomics and breast cancer. Pharmacogenomics 9, 1879-1902.
10. Takai, D. and Jones, P. A. (2002) Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl. Acad. Sci. U. S. A 99, 3740-3745. (Pubitemid 34252176)
11. Esteller, M., Corn, P. G., Baylin, S. B., and Herman, J. G. (2001) A gene hypermethylation profile of human cancer. Cancer Res. 61, 3225-3229. (Pubitemid 32695003)
12. Esteller, M. (2007) Cancer epigenomics: DNA methylomes and histone-modifi cation maps. Nat. Rev. Genet. 8, 286-298. (Pubitemid 46439286)
13. Greger, V., Passarge, E., Hopping, W., Messmer, E., and Horsthemke, B. (1989) Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum. Genet. 83, 155-158. (Pubitemid 19234564)
14. Brooks, J., Cairns, P., and Zeleniuch-Jacquotte, A. (2009) Promoter methylation and the detection of breast cancer. Cancer Causes Control 20, 1539-1550.
15. van Hoesel, A. Q., Van, d., V, Kuppen, P. J., Putter, H., de Kruijf, E. M., van Nes, J. G., Giuliano, A. E., and Hoon, D. S. (2011) Primary tumor classifi cation according to methylation pattern is prognostic in patients with early stage ER-negative breast cancer. Breast Cancer Res. Treat 16. Fang, F., Turcan, S., Rimner, A., Kaufman, A., Giri, D., Morris, L. G., Shen, R., Seshan, V., Mo, Q., et al. (2011) Breast cancer methylomes establish an epigenomic foundation for metastasis. Sci Transl Med 3, 75ra25.
16. Hu, X. C., Wong, I. H., and Chow, L. W. (2003) Tumor-derived aberrant methylation in plasma of invasive ductal breast cancer patients: Clinical implications. Oncol Rep 10, 1811-1815.
17. Mirza, S., Sharma, G., Prasad, C. P., Parshad, R., Srivastava, A., Gupta, S. D., and Ralhan, R. (2007) Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Life Sci 81, 280-287. (Pubitemid 47030571)
18. Sharma, G., Mirza, S., Prasad, C. P., Srivastava, A., Gupta, S. D., and Ralhan, R. (2007) Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients. Life Sci 80, 1873-1881. (Pubitemid 46562520)
19. Dulaimi, E., Hillinck, J., Ibanez, d. C., I, Al-Saleem, T., and Cairns, P. (2004) Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Clin. Cancer Res. 10, 6189-6193. (Pubitemid 39287525)
20. Radpour, R., Barekati, Z., Kohler, C., Lv, Q., Burki, N., Diesch, C., Bitzer, J., Zheng, H., Schmid, S., and Zhong, X. Y. (2011) Hypermethylation of tumor suppressor genes involved in critical regulatory pathways for developing a blood-based test in breast cancer. PLoS One 6, e16080.
21. Lujambio, A., Ropero, S., Ballestar, E., Fraga, M. F., Cerrato, C., Setien, F., Casado, S., Suarez-Gauthier, A., Sanchez-Cespedes, M., et al. (2007) Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 67, 1424-1429. (Pubitemid 46383366)
22. O'Day, E. and Lal, A. (2010) MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res. 12, 201.
23. Veeck, J. and Esteller, M. (2010) Breast cancer epigenetics: From DNA methylation to microRNAs. J Mammary Gland Biol Neoplasia 15, 5-17.
24. Blenkiron, C., Goldstein, L. D., Thorne, N. P., Spiteri, I., Chin, S. F., Dunning, M. J., Barbosa-Morais, N. L., Teschendorff, A. E., Green, A. R., et al. (2007) MicroRNA expression profi ling of human breast cancer identifi es new markers of tumor subtype. Genome Biol 8, R214.
25. Liu, J., Getz, G., Miska, E. Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., et al. (2005) MicroRNA expression profi les classify human cancers. Nature 435, 834-838. (Pubitemid 40839735)
26. Foekens, J. A., Sieuwerts, A. M., Smid, M., Look, M. P., de, W., V, Boersma, A. W., Klijn, J. G., Wiemer, E. A. and Martens, J. W. (2008) Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc. Natl. Acad. Sci. U. S. A 105, 13021-13026.
27. de Souza Rocha, S. P., Breiling, A., Gupta, N., Malekpour, M., Youns, M., Omranipour, R., Malekpour, F., Volinia, S., Croce, C. M., et al. (2010) Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res. 70, 9175-9184.
28. Png, K. J., Yoshida, M., Zhang, X. H., Shu, W., Lee, H., Rimner, A., Chan, T. A., Comen, E., Andrade, V. P., et al. (2011) MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes. Dev. 25, 226-231.
29. Ehrlich, M. (2002) DNA hypomethylation, cancer, the immunodefi ciency, centromeric region instability, facial anomalies syndrome and chromosomal rearrangements. J Nutr 132, 2424 S-2429 S. (Pubitemid 34848120)
30. Jones, P. A. and Baylin, S. B. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415-428. (Pubitemid 34587077)
31. Soares, J., Pinto, A. E., Cunha, C. V., Andre, S., Barao, I., Sousa, J. M., and Cravo, M. (1999) Global DNA hypomethylation in breast carcinoma: Correlation with prognostic factors and tumor progression. Cancer 85, 112-118. (Pubitemid 29031364)
32. Jackson, K., Yu, M. C., Arakawa, K., Fiala, E., Youn, B., Fiegl, H., Muller-Holzner, E., Widschwendter, M., and Ehrlich, M. (2004) DNA hypomethylation is prevalent even in low-grade breast cancers. Cancer Biol Ther 3, 1225-1231. (Pubitemid 41350957)
33. Choi, J. Y., James, S. R., Link, P. A., McCann, S. E., Hong, C. C., Davis, W., Nesline, M. K., Ambrosone, C. B., and Karpf, A. R. (2009) Association between global DNA hypomethy lation in leukocytes and risk of breast cancer. Carcinogenesis 30, 1889-1897.
34. Cho, Y. H., Yazici, H., Wu, H. C., Terry, M. B., Gonzalez, K., Qu, M., Dalay, N., and Santella, R. M. (2010) Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients. Anticancer Res 30, 2489-2496.
35. Loree, J., Koturbash, I., Kutanzi, K., Baker, M., Pogribny, I., and Kovalchuk, O. (2006) Radiation-induced molecular changes in rat mammary tissue: Possible implications for radiation-induced carcinogenesis. Int J Radiat Biol 82, 805-815. (Pubitemid 44915736)
36. Shukla, V., Coumoul, X., Lahusen, T., Wang, R. H., Xu, X., Vassilopoulos, A., Xiao, C., Lee, M. H., Man, Y. G., et al. (2010) BRCA1 affects global DNA methylation through regulation of DNMT1. Cell Res 20, 1201-1215.
37. Schubeler, D., MacAlpine, D. M., Scalzo, D., Wirbelauer, C., Kooperberg, C., van, L. F., Gottschling, D. E., O'Neill, L. P., Turner, B. M., et al. (2004) The histone modifi cation pattern of active genes revealed through genomewide chromatin analysis of a higher eukaryote. Genes. Dev. 18, 1263-1271. (Pubitemid 38720594)
38. Shiio, Y. and Eisenman, R. N. (2003) Histone sumoylation is associated with transcriptional repression. Proc. Natl. Acad. Sci. U. S. A 100, 13225-13230. (Pubitemid 37444723)
39. Shilatifard, A. (2006) Chromatin modifi cations by methylation and ubiquitination: Implications in the regulation of gene expression. Annu Rev Biochem 75, 243-269. (Pubitemid 44118033)
40. Barski, A., Cuddapah, S., Cui, K., Roh, T. Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., and Zhao, K. (2007) High-resolution profi ling of histone methylations in the human genome. Cell 129, 823-837. (Pubitemid 46802390)
41. Wang, Z., Zang, C., Rosenfeld, J. A., Schones, D. E., Barski, A., Cuddapah, S., Cui, K., Roh, T. Y., Peng, W., et al. (2008) Combinatorial patterns of histone acetylations and methylations in the human genome. Nat. Genet. 40, 897-903. (Pubitemid 351913645)
42. Bernstein, B. E., Kamal, M., Lindblad-Toh, K., Bekiranov, S., Bailey, D. K., Huebert, D. J., McMahon, S., Karlsson, E. K., Kulbokas, E. J., III et al. (2005) Genomic maps and comparative analysis of histone modifi cations in human and mouse. Cell 120, 169-181. (Pubitemid 40174761)
43. Schneider, R., Bannister, A. J., Myers, F. A., Thorne, A. W., Crane-Robinson, C., and Kouzarides, T. (2004) Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat Cell Biol 6, 73-77. (Pubitemid 38425733)
44. Jenuwein, T. and Allis, C. D. (2001) Translating the histone code. Science 293, 1074-1080. (Pubitemid 32758077)
45. Kouzarides, T. (2007) Chromatin modifi cations and their function. Cell 128, 693-705. (Pubitemid 46273577)
46. Fraga, M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., et al. (2005) Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat. Genet. 37, 391-400.
47. Elsheikh, S. E., Green, A. R., Rakha, E. A., Powe, D. G., Ahmed, R. A., Collins, H. M., Soria, D., Garibaldi, J. M., Paish, C. E., et al. (2009) Global histone modifi cations in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res. 69, 3802-3809.
48. Wang, Z., Zang, C., Cui, K., Schones, D. E., Barski, A., Peng, W., and Zhao, K. (2009) Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 138, 1019-1031.
49. Dalvai, M. and Bystricky, K. (2010) The role of histone modifi cations and variants in regulating gene expression in breast cancer. J Mammary Gland Biol Neoplasia 15, 19-33.
50. Iyer, N. G., Ozdag, H., and Caldas, C. (2004) p300/CBP and cancer. Oncogene 23, 4225-4231. (Pubitemid 38758588)
51. Avvakumov, N. and Cote, J. (2007) The MYST family of histone acetyltransferases and their intimate links to cancer. Oncogene 26, 5395-5407. (Pubitemid 47255922)
52. Iizuka, M., Takahashi, Y., Mizzen, C. A., Cook, R. G., Fujita, M., Allis, C. D., Frierson, H. F., Jr., Fukusato, T., and Smith, M. M. (2009) Histone acetyltransferase Hbo1: Catalytic activity, cellular abundance, and links to primary cancers. Gene 436, 108-114.
53. Hyman, E., Kauraniemi, P., Hautaniemi, S., Wolf, M., Mousses, S., Rozenblum, E., Ringner, M., Sauter, G., Monni, O., et al. (2002) Impact of DNA amplifi cation on gene expression patterns in breast cancer. Cancer Res. 62, 6240-6245. (Pubitemid 35244477)
54. Pfi ster, S., Rea, S., Taipale, M., Mendrzyk, F., Straub, B., Ittrich, C., Thuerigen, O., Sinn, H. P., Akhtar, A., and Lichter, P. (2008) The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma. Int J Cancer 122, 1207-1213. (Pubitemid 351287218)
55. Feng, W., Lu, Z., Luo, R. Z., Zhang, X., Seto, E., Liao, W. S., and Yu, Y. (2007) Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer. Int J Cancer 120, 1664-1668. (Pubitemid 46399351)
56. Yu, Y., Xu, F., Peng, H., Fang, X., Zhao, S., Li, Y., Cuevas, B., Kuo, W. L., Gray, J. W., et al. (1999) NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc. Natl. Acad. Sci. U. S. A 96, 214-219. (Pubitemid 29036079)
57. Suzuki, J., Chen, Y. Y., Scott, G. K., DeVries, S., Chin, K., Benz, C. C., Waldman, F. M., and Hwang, E. S. (2009) Protein acetylation and histone deacetylase expression associated with malignant breast cancer progression. Clin. Cancer Res. 15, 3163-3171.
58. Zhang, Z., Yamashita, H., Toyama, T., Sugiura, H., Omoto, Y., Ando, Y., Mita, K., Hamaguchi, M., Hayashi, S., and Iwase, H. (2004) HDAC6 expression is correlated with better survival in breast cancer. Clin. Cancer Res. 10, 6962-6968. (Pubitemid 39383047)
59. Duong, V., Bret, C., Altucci, L., Mai, A., Duraffourd, C., Loubersac, J., Harmand, P. O., Bonnet, S., Valente, S., et al. (2008) Specific activity of class II histone deacetylases in human breast cancer cells. Mol Cancer Res. 6, 1908-1919.
60. Park, S. Y., Jun, J. A., Jeong, K. J., Heo, H. J., Sohn, J. S., Lee, H. Y., Park, C. G., and Kang, J. (2011) Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer. Oncol Rep 25, 1677-1681.
61. Huang, Y., Vasilatos, S. N., Boric, L., Shaw, P. G., and Davidson, N. E. (2011) Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells. Breast Cancer Res. Treat .
62. Sparmann, A. and van, L. M. (2006) Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 6, 846-856. (Pubitemid 44629896)
63. Ballestar, E. and Esteller, M. (2005) The epigenetic breakdown of cancer cells: From DNA methylation to histone modifi cations. Prog Mol Subcell Biol 38, 169-181.
64. Meissner, A., Mikkelsen, T. S., Gu, H., Wernig, M., Hanna, J., Sivachenko, A., Zhang, X., Bernstein, B. E., Nusbaum, C., et al. (2008) Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454, 766-770.
65. Hinshelwood, R. A., Melki, J. R., Huschtscha, L. I., Paul, C., Song, J. Z., Stirzaker, C., Reddel, R. R., and Clark, S. J. (2009) Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning. Hum Mol Genet 18, 3098-3109.
66. Cheng, A. S., Culhane, A. C., Chan, M. W., Venkataramu, C. R., Ehrich, M., Nasir, A., Rodriguez, B. A., Liu, J., Yan, P. S., et al. (2008) Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome. Cancer Res. 68, 1786-1796. (Pubitemid 351416564)
67. Dimri, G. P., Martinez, J. L., Jacobs, J. J., Keblusek, P., Itahana, K., van, L. M., Campisi, J., Wazer, D. E., and Band, V. (2002) The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res. 62, 4736-4745.
68. Kleer, C. G., Cao, Q., Varambally, S., Shen, R., Ota, I., Tomlins, S. A., Ghosh, D., Sewalt, R. G., Otte, A. P., et al. (2003) EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. P roc Natl Acad Sci U. S. A 100, 11606-11611. (Pubitemid 37205983)
69. Lehnertz, B., Ueda, Y., Derijck, A. A., Braunschweig, U., Perez-Burgos, L., Kubicek, S., Chen, T., Li, E., Jenuwein, T., and Peters, A. H. (2003) Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 13, 1192-1200. (Pubitemid 36872941)
70. Giacinti, L., Claudio, P. P., Lopez, M., and Giordano, A. (2006) Epigenetic information and estrogen receptor alpha expression in breast cancer. Oncologist 11, 1-8. (Pubitemid 43152681)